WF Woori posts 55 Q4 2025 EPS miss against analyst forecasts sending shares down nearly 5 today Is Tarsus Pharmaceuticals TARS stock failing to hold levels Tarsus Pharmaceuticals posts wider than expected EPS loss EURK Eureka management focuses on sustainable tech acquisition targets to drive longterm shareholder value